-
The genomics of resistance to immunodeficiency virus (GRIV) Cohort was established in France in 1995 to generate a large database for genetic studies to identify host genes associated with rapid progression and long-term non-progression to AIDS.
-
In this study, 296 previously healthy eligible adults ages 20-64 with onset of influenza-like symptoms within the previous 48 hours and a positive rapid antigen test were enrolled in a double-blind, placebo-controlled trial conducted at Nagasaki University.
-
A randomized, double-blind, placebo-controlled trial of the efficacy of oral oseltamivir twice daily started within 24 hours of onset of influenza symptoms (fever, plus cough, rhinitis, or sore throat) was conducted in children 1-3 years of age at a single primary care study site in Finland during the 2007-2008 and 2008-2009 influenza seasons.
-
The introduction of accellular pertussis vaccines represented an important advance in public health, but developing a vaccine is not synonymous with protecting a population.
-
The purpose of this study was to estimate the association between antibacterial medications and selected birth defects.
-
A 39-year-old man had traveled for four weeks to the Pantanal region of Brazil, a popular ecotourism area, where he had walked barefoot on several occasions.
-
Although there is little data to support this, I routinely counsel my HIV-infected patients to get seasonal and H1N1 vaccine, explaining that while they are probably at no greater risk for "catching the flu," they may be at greater risk for more severe symptoms and complications than someone without HIV.
-
In this issue: FDA Advisory Committee recommends approval of dabigatran, safety of proton pump inhibitors, effectiveness of glucosamine and chondroitin, FDA Actions.
-
-
Initial association analysis was performed on 205 african-americans with biopsy-proven FSGS and 180 African-American controls.
